Merios
Metabolic Health

Fasting Glucose 100 or 110 mg/dL: Borderline or Prediabetic?

Fasting glucose of 100 to 125 mg/dL is prediabetes. What 100 and 110 mean, how fast each tends to progress, and how to bring the number back down.

OCT 12, 20265 MIN READMETABOLIC HEALTHMERIOS EDITORIAL
Contents
  1. Is Fasting Glucose 100 mg/dL Bad?
  2. Where Does 100 mg/dL Fall?
  3. Why 100 mg/dL Is the Critical Window
  4. What to Do at 100 mg/dL — Order by Impact
  5. Fasting Glucose 110 mg/dL
  6. Don't Test Glucose Alone — The Combo That Matters
  7. Recheck Schedule
  8. How Merios Tracks This
  9. Related Reading
  10. Sources

Is Fasting Glucose 100 mg/dL Bad?

Fasting glucose 100 mg/dL sits exactly at the prediabetes threshold. Below 100 = "normal" by ADA criteria. 100–125 = impaired fasting glucose (prediabetes). 126+ = diabetes. (The WHO starts impaired fasting glucose at 110 mg/dL, so outside the US a 100 may still be reported as normal.)1 So 100 is the wake-up call number — early, often reversible, but not something to ignore.2 A continuous glucose monitor shows the same story minute by minute — covered in using a CGM without diabetes.

Where Does 100 mg/dL Fall?

CategoryFasting Glucose (mg/dL)
Optimal (longevity)72–85
Normal (clinical)70–99
Your value (100 mg/dL)Impaired fasting glucose
Prediabetes100–125
Diabetes>=126

The ADA's "normal" cutoff (99 mg/dL) is not a cliff edge. In pooled data from 97 cohorts, fasting glucose above 100 mg/dL — but not 70–100 — was linked to a higher risk of death,3 while future diabetes risk still rose within the normal range, from about 87 mg/dL, in a large cohort of young men.4 The longevity-focused target is <85 mg/dL if possible.

Why 100 mg/dL Is the Critical Window

At 100, you're at the threshold of reversibility. Research is clear:

  • The Diabetes Prevention Program (NEJM 2002) showed lifestyle intervention (7% weight loss + 150 min/week activity) reduced progression to type 2 diabetes by 58% over 3 years — better than metformin (31%).5
  • Lifestyle change moves the number, but gradually: in trials of people with prediabetes, resistance or interval training programs of 12+ weeks lowered fasting glucose by about 5–7 mg/dL on average.6
  • Past 110, the trajectory accelerates: in one large health-plan cohort, impaired fasting glucose that started at 110–125 progressed to diabetes at 5.6% a year, versus 1.3% for 100–109.7

What to Do at 100 mg/dL — Order by Impact

  1. Reduce refined carbs and added sugars — single biggest dietary lever. Swap white bread, pasta, sugar-sweetened drinks for whole grains, legumes, water/unsweetened tea.8
  2. Strength training 2–3×/week — builds muscle = better glucose disposal.9 In trials in type 2 diabetes, combining it with cardio beat either one alone for glucose control.10
  3. 10-minute post-meal walks — in a trial in type 2 diabetes, a 10-minute walk after each meal left post-meal glucose 12% lower than one daily 30-minute walk did (22% lower after dinner). Trivial effort, real impact.11
  4. Sleep 7+ hours — a single night of 4 hours' sleep cut insulin sensitivity by about 25% in healthy adults.1213
  5. Drop 5–10% body weight if overweight — directly improves insulin sensitivity.14

Fasting Glucose 110 mg/dL

110 is mid-range prediabetes, past the early edge of 100 and exactly where the WHO's narrower impaired fasting glucose range (110–125 mg/dL) begins.1 A high fasting number usually means the liver is releasing glucose overnight faster than insulin can clear it, which is a different mechanism from the after-meal spike, driven more by insulin resistance in muscle.15

It also often disagrees with A1C: in US national survey data, only about a quarter of adults with impaired fasting glucose also had a prediabetic A1C (5.7–6.4%).16 If your fasting glucose is 110 but your A1C is normal, the overnight number may be the early signal; if A1C is high too, daytime spikes are adding up. What 5.7%, 5.8% and 6.0% mean covers the A1C side.

Two habits target the overnight number specifically. In a small trial in men with prediabetes, eating within an early 6-hour window (dinner before 3 p.m.) improved insulin sensitivity even without weight loss,17 and in a crossover trial, the same dinner eaten at 10 p.m. instead of 6 p.m. kept glucose higher overnight.18 Everything in the list above applies too.

Don't Test Glucose Alone — The Combo That Matters

Fasting glucose tells you what your blood sugar IS at one moment. But the bigger signal is what your body is doing to keep it there:

  • Fasting insulin (no universal reference range — assays differ between labs) — high insulin with normal glucose = your pancreas is working overtime1920
  • HOMA-IR = fasting glucose × fasting insulin / 405 (the model defines 1.0 as normal)2122
  • HbA1c (optimal <5.5%)23 — your 90-day glucose average

If you do not have a fasting insulin result, the TyG index calculator estimates insulin resistance from triglycerides and glucose alone.

Use the HOMA-IR calculator to compute your insulin resistance score from the same fasted draw. A HOMA-IR above 2.5 alongside a fasting glucose of 100 mg/dL points toward insulin resistance, and scores between 2.0 and 2.5 are a gray zone. Cutoffs vary by population — published thresholds run from under 2 to about 3.5 — so bring the number to your physician rather than reading it as a diagnosis.24

Recheck Schedule

  • Week 12: recheck fasting glucose, fasting insulin, HbA1c after lifestyle change
  • If FG dropped to <90: keep going, you're winning
  • If FG is still 100+ at week 12: tighten the protocol and ask your physician whether metformin fits — the ADA suggests considering it in higher-risk prediabetes, for example with a BMI of 35+, fasting glucose of 110+, A1C of 6.0%+ or prior gestational diabetes25

How Merios Tracks This

Merios pulls fasting glucose, fasting insulin, HOMA-IR, and HbA1c from any standard panel and tracks them longitudinally. The Merios Score reflects metabolic pillar progress — so you see your 12-week experiment paying off (or not) at a glance, not just one snapshot.

Try Merios free →

Sources

25 references · checked October 12, 2026

  1. 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes-2025. Diabetes Care, 2025.PMID 39651986DOI
  2. Tabák AG, Herder C, Rathmann W, et al. Prediabetes: a high-risk state for diabetes development. Lancet, 2012.PMID 22683128DOI
  3. Rao Kondapally Seshasai S, Kaptoge S, Thompson A, et al. Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med, 2011.PMID 21366474DOI
  4. Tirosh A, Shai I, Tekes-Manova D, et al. Normal fasting plasma glucose levels and type 2 diabetes in young men. N Engl J Med, 2005.PMID 16207847DOI
  5. Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med, 2002.PMID 11832527DOI
  6. Bennasar-Veny M, Malih N, Galmes-Panades AM, et al. Effect of physical activity and different exercise modalities on glycemic control in people with prediabetes: a systematic review and meta-analysis of randomized controlled trials. Front Endocrinol (Lausanne), 2023.PMID 37842295DOI
  7. Nichols GA, Hillier TA, Brown JB. Progression from newly acquired impaired fasting glusose to type 2 diabetes. Diabetes Care, 2007.PMID 17259486DOI
  8. Evert AB, Dennison M, Gardner CD, et al. Nutrition Therapy for Adults With Diabetes or Prediabetes: A Consensus Report. Diabetes Care, 2019.PMID 31000505DOI
  9. Srikanthan P, Karlamangla AS. Relative muscle mass is inversely associated with insulin resistance and prediabetes. Findings from the third National Health and Nutrition Examination Survey. J Clin Endocrinol Metab, 2011.PMID 21778224DOI
  10. Schwingshackl L, Missbach B, Dias S, et al. Impact of different training modalities on glycaemic control and blood lipids in patients with type 2 diabetes: a systematic review and network meta-analysis. Diabetologia, 2014.PMID 24996616DOI
  11. Reynolds AN, Mann JI, Williams S, et al. Advice to walk after meals is more effective for lowering postprandial glycaemia in type 2 diabetes mellitus than advice that does not specify timing: a randomised crossover study. Diabetologia, 2016.PMID 27747394DOI
  12. Donga E, van Dijk M, van Dijk JG, et al. A single night of partial sleep deprivation induces insulin resistance in multiple metabolic pathways in healthy subjects. J Clin Endocrinol Metab, 2010.PMID 20371664DOI
  13. About Sleep. Centers for Disease Control and Prevention, 2024.
  14. Magkos F, Fraterrigo G, Yoshino J, et al. Effects of Moderate and Subsequent Progressive Weight Loss on Metabolic Function and Adipose Tissue Biology in Humans with Obesity. Cell Metab, 2016.PMID 26916363DOI
  15. Abdul-Ghani MA, Tripathy D, DeFronzo RA. Contributions of beta-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose. Diabetes Care, 2006.PMID 16644654DOI
  16. Mann DM, Carson AP, Shimbo D, et al. Impact of A1C screening criterion on the diagnosis of pre-diabetes among U.S. adults. Diabetes Care, 2010.PMID 20628087DOI
  17. Sutton EF, Beyl R, Early KS, et al. Early Time-Restricted Feeding Improves Insulin Sensitivity, Blood Pressure, and Oxidative Stress Even without Weight Loss in Men with Prediabetes. Cell Metab, 2018.PMID 29754952DOI
  18. Gu C, Brereton N, Schweitzer A, et al. Metabolic Effects of Late Dinner in Healthy Volunteers-A Randomized Crossover Clinical Trial. J Clin Endocrinol Metab, 2020.PMID 32525525DOI
  19. Marcovina S, Bowsher RR, Miller WG, et al. Standardization of insulin immunoassays: report of the American Diabetes Association Workgroup. Clin Chem, 2007.PMID 17272483DOI
  20. Defronzo RA. Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus. Diabetes, 2009.PMID 19336687DOI
  21. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 1985.PMID 3899825DOI
  22. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care, 2004.PMID 15161807DOI
  23. Selvin E, Steffes MW, Zhu H, et al. Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med, 2010.PMID 20200384DOI
  24. Gayoso-Diz P, Otero-González A, Rodriguez-Alvarez MX, et al. Insulin resistance (HOMA-IR) cut-off values and the metabolic syndrome in a general adult population: effect of gender and age: EPIRCE cross-sectional study. BMC Endocr Disord, 2013.PMID 24131857DOI
  25. 3. Prevention or Delay of Diabetes and Associated Comorbidities: Standards of Care in Diabetes-2025. Diabetes Care, 2025.PMID 39651971DOI

Frequently asked questions

  • Is fasting glucose 100 mg/dL pre-diabetic?
    Yes — 100 mg/dL is the lower boundary of the impaired fasting glucose range (100–125 mg/dL), which is the official ADA prediabetes definition. (The WHO starts impaired fasting glucose at 110 mg/dL, so by its criteria 100 is still normal.) You're not yet diabetic (>=126), but you're past optimal (72–85 mg/dL), and the trajectory deserves attention.
  • How fast can I lower fasting glucose from 100 to under 90?
    It varies, and it is usually gradual. In trials of people with prediabetes, exercise programs of 12 weeks or more lowered fasting glucose by about 5–7 mg/dL on average, so plan on sustained change: lower refined carbs, structured strength training 2–3×/week, 7+ hours sleep, and 10-minute post-meal walks, then recheck at 12 weeks.
  • Should I get HbA1c tested too?
    Yes. Fasting glucose is a single moment; HbA1c reflects average blood sugar over the past 2–3 months. If glucose is 100, also check HbA1c — if HbA1c is below 5.7%, your 3-month average is still in the normal range. If HbA1c is 5.7–6.4%, you're confirming prediabetes and should act.
  • Is a fasting glucose of 110 bad?
    110 mg/dL is impaired fasting glucose — prediabetes — in the middle of the ADA's 100–125 range and at the start of the WHO's narrower 110–125 range. It's not diabetes (that starts at 126), but it signals early insulin resistance worth acting on, and readings of 110–125 progress to diabetes faster than readings of 100–109.
Keep reading

More from the Journal

Wearables

Do You Need a CGM If You're Not Diabetic? What the Data Says

Continuous glucose monitors are booming among healthy people. Here's what a CGM actually shows if you're not diabetic — and when it's worth it.

JUL 15, 20268 MIN READ
Metabolic Health

HbA1c 6.5%: The Diabetes Threshold — What It Means and What to Do Next

HbA1c 6.5% is the diabetes threshold. What 6.5% means, your estimated average glucose, and the concrete steps to take next to lower it.

JUN 4, 20266 MIN READ
Metabolic Health

Type 2 Diabetes vs LADA: How Blood Tests Tell Them Apart

Type 2 diabetes vs LADA: learn how GAD antibodies and C-peptide blood tests differentiate these conditions and affect treatment.

APR 24, 20267 MIN READ
Newsletter

Like this? Get the next one in your inbox.

Merios is live on the US App Store — plus a weekly briefing with new biomarker deep-dives and plain-English study breakdowns.

Get the app